New hope for Tough-to-Treat blood cancer: experimental drug enters human testing
NCT ID NCT05650632
First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 4 times
Summary
This study tests an experimental drug called etentamig (ABBV-383) in about 210 adults whose multiple myeloma has come back or stopped responding to other treatments. The main goals are to find the best dose and check for side effects. Participants receive the drug as an infusion every 28 days for up to 3 years, with regular monitoring at the clinic.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP - Hopital Saint-Antoine /ID# 252326
COMPLETEDParis, 75012, France
-
Atrium Health Wake Forest Baptist Medical Center /ID# 251165
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Baptist Memorial Hospital /ID# 280677
NOT_YET_RECRUITINGMemphis, Tennessee, 38120, United States
-
CHU Poitiers - La miletrie /ID# 251219
RECRUITINGPoitiers, Vienne, 86000, France
-
Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 251196
RECRUITINGNantes, Pays de la Loire Region, 44000, France
-
Fort Wayne Medical Oncology And Hematology /ID# 268179
RECRUITINGFort Wayne, Indiana, 46804, United States
-
Franciscan St. Francis Health /ID# 280928
RECRUITINGIndianapolis, Indiana, 46237, United States
-
Fred Hutchinson Cancer Center. /ID# 267940
RECRUITINGSeattle, Washington, 98109-4405, United States
-
HCL - Hopital Lyon Sud /ID# 251223
RECRUITINGPierre-Bénite, Rhone, 69495, France
-
Hadassah Medical Center-Hebrew University /ID# 252079
RECRUITINGJerusalem, Jerusalem, 91120, Israel
-
Highlands Oncology Group - Springdale /ID# 267742
RECRUITINGSpringdale, Arkansas, 72762, United States
-
Hope And Healing Cancer Services /ID# 268536
RECRUITINGHinsdale, Illinois, 60521, United States
-
Hopitaux Universitaires Henri Mondor - Hopital Henri Mondor /ID# 252101
COMPLETEDCréteil, Paris, 94010, France
-
Hospital Universitario Marques de Valdecilla /ID# 251528
RECRUITINGSantander, Cantabria, 39008, Spain
-
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 251545
COMPLETEDMajadahonda, Madrid, 28222, Spain
-
Hospital Universitario de Salamanca /ID# 251529
RECRUITINGSalamanca, 37711, Spain
-
Institut Paoli-Calmettes /ID# 252100
COMPLETEDMarseille, Bouches-du-Rhone, 13009, France
-
Juravinski Cancer Centre /ID# 252053
RECRUITINGHamilton, Ontario, L8V 1C3, Canada
-
Maryland Oncology Hematology - Silver Spring /ID# 268562
NOT_YET_RECRUITINGSilver Spring, Maryland, 20904, United States
-
Mayo Clinic - Rochester /ID# 251164
RECRUITINGRochester, Minnesota, 55905-0001, United States
-
Mayo Clinic Arizona /ID# 251405
RECRUITINGPhoenix, Arizona, 85054, United States
-
Medical Oncology Hematology Consultants /ID# 268560
RECRUITINGNewark, Delaware, 19713, United States
-
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 251167
RECRUITINGNew York, New York, 10065-6007, United States
-
Mt Sinai /ID# 251166
RECRUITINGNew York, New York, 10029-6542, United States
-
NHO Revive Research Institute, LLC /ID# 267869
RECRUITINGLincoln, Nebraska, 68506, United States
-
Nebraska Cancer Specialists - Omaha - Wright Street /ID# 282497
RECRUITINGOmaha, Nebraska, 68130, United States
-
Northwest Medical Specialties Tacoma /ID# 267117
RECRUITINGTacoma, Washington, 98405, United States
-
Odense University Hospital /ID# 251261
RECRUITINGOdense, Region Syddanmark, 5000, Denmark
-
Oncology Consultants /ID# 268323
RECRUITINGHouston, Texas, 77030, United States
-
Ottawa Hospital Research Institute /ID# 252151
COMPLETEDOttawa, Ontario, K1H 8L6, Canada
-
Rabin Medical Center. /ID# 251330
RECRUITINGPetah Tikva, Central District, 4941492, Israel
-
Rocky Mountain Cancer Centers - Aurora /ID# 268574
RECRUITINGAurora, Colorado, 80012, United States
-
Tel Aviv Sourasky Medical Center /ID# 251573
RECRUITINGTel Aviv, Tel Aviv, 6423906, Israel
-
Texas Oncology - Central/South Texas /ID# 268563
RECRUITINGAustin, Texas, 78705, United States
-
Texas Oncology - Dallas - Worth Street /ID# 280064
RECRUITINGDallas, Texas, 75246, United States
-
Texas Oncology - Northeast Texas /ID# 268877
RECRUITINGTyler, Texas, 75702, United States
-
The Chaim Sheba Medical Center /ID# 251329
RECRUITINGRamat Gan, Tel Aviv, 5265601, Israel
-
The Christie Hospital /ID# 251774
RECRUITINGManchester, M20 4BX, United Kingdom
-
Tulane University School of Medicine /ID# 251204
RECRUITINGNew Orleans, Louisiana, 70112, United States
-
University College London Hospital /ID# 251357
RECRUITINGLondon, Greater London, NW1 2BU, United Kingdom
-
University Of Cincinnati Medical Center /ID# 251746
RECRUITINGCincinnati, Ohio, 45219, United States
-
University of North Carolina /ID# 251203
RECRUITINGChapel Hill, North Carolina, 27514, United States
-
Vanderbilt Ingram Cancer Center /ID# 252470
RECRUITINGNashville, Tennessee, 37232-0021, United States
-
Vejle Sygehus /ID# 251260
RECRUITINGVejle, Region Syddanmark, 7100, Denmark
-
Virginia Cancer Specialists - Fairfax /ID# 268559
RECRUITINGFairfax, Virginia, 22031, United States
-
Willamette Valley Cancer Institute and Research Center /ID# 267088
RECRUITINGEugene, Oregon, 97401, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact